(ii) Knockout of NLRP3 genes or pharmacological blockage can alleviate OSA-associated neurocognitive impairment, pulmonary hypertension, cardiac injury, T2DM, and renal injury. Here, NLRP3 is linked to type 2 diabetes mellitus.